ANG Lifesciences has submitted a certificate from its Registrar and Share Transfer Agent, confirming the diligent processing of shareholder requests to convert physical shares into electronic form.

The company’s RTA confirmed that all securities received for dematerialization were properly processed and listed on the stock exchange.

Furthermore, physical share certificates were cancelled after due verification, and depository records were updated promptly.

This assures investors of efficient and transparent management of their shareholdings, maintaining robust operational compliance for shareholder services.